Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Is Moderna Stock A Buy As It Faces Off With Pfizer, GSK In The Massive RSV Market?
11:21am, Wednesday, 15'th Feb 2023
Is Moderna stock a buy after unveiling promising results for its Pfizer- and GSK-rivaling RSV vaccine? Is MRNA stock a buy now?
Dividend Income Update: January 2023
07:30am, Monday, 13'th Feb 2023
Dividends may not increase every year and a cut or elimination is even possible but the odds are greatly reduced when you diversify among different companies and sectors and focus on dividend quality.
Dividend Income Summary: Lanny's January 2023 Summary
06:01am, Saturday, 11'th Feb 2023
Investing in dividend stocks allows you to earn dividend income, the best passive income stream. Dividend Income is the fruit from the labor of investing your money in the stock market.
GSK cancer drug gets the FDA green light
02:59am, Friday, 10'th Feb 2023
GSK PLC (LSE:GSK, NYSE:GSK) said that the US Food and Drug Administration (FDA) has granted full approval for Jemperli, a drug for the treatment of mismatch repair-deficient endometrial cancer in adul
Is Biotech Immunocore About To Make A 25% Price Move?
07:00am, Tuesday, 07'th Feb 2023
The industry is home to some large-cap heavyweights, including Amgen Inc. (NASDAQ: AMGN), Gilead Sciences Inc. (NASDAQ: GILD), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Vertex Pharmaceuticals Inc
GSK's Innovative Specialty Products Need More Insurance Coverage, Still A Buy
01:33am, Friday, 03'rd Feb 2023
Rukobia is a bright spot, but it's a pill, thus enjoying almost universal coverage. Kaiser Permanente recognizes their worth.
GSK's Daprodustat Drug for Anemia Due to CKD Gets FDA Nod
06:04pm, Thursday, 02'nd Feb 2023
GSK announces the FDA approval of daprodustat for the treatment of anemia due to chronic kidney disease (CKD) in adults on dialysis for at least four months.
GSK: Top investment bank has its say after drug giant's better-than-expected results
06:49am, Thursday, 02'nd Feb 2023
The current year looks to be ‘shaping up nicely' for GSK PLC (LSE:GSK, NYSE:GSK), according to Barclays Capital in the wake of Wednesday's fourth-quarter and full-year results. It did, however, say
GSK chronic kidney disease drug receives green light
05:58am, Thursday, 02'nd Feb 2023
The US Food and Drug Administration (FDA) has given the green light to Jesduvroq, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) for the treatment of adults with chronic kidne
GSK Shows That The COVID-19 Show Is Passing
05:10pm, Wednesday, 01'st Feb 2023
As predicted by some epidemiologists at the onset of the pandemic, COVID-19 would become an endemic flu-like condition not warranting mandated concern. The growth in sales of COVID-19 therapies and di
GSK's Beats on Q4 Earnings & Sales, Issues Upbeat 2023 Outlook
12:02pm, Wednesday, 01'st Feb 2023
GSK's (GSK) revenues benefit from strong growth in sales across all segments, especially Shingrix vaccine sales. The company also issues fresh 2023 guidance for all its segments.
GSK plc (GSK) Q4 2022 Earnings Call Transcript
10:25am, Wednesday, 01'st Feb 2023
GSK plc (NYSE:GSK ) Q4 2022 Earnings Conference Call February 1, 2023 6:00 AM ET Company Participants Nick Stone - Head, Global Investor Relations Emma Walmsley - CEO & Director Tony Wood - Chief Scie
GSK CEO Emma Walmsley on beating Q4 earnings
09:29am, Wednesday, 01'st Feb 2023
GlaxoSmithKline CEO Emma Walmsley joins 'Squawk Box' to discuss company's growth drivers this quarter, the company's Shingles vaccine and the medical giant's RSV vaccine.
Pharma Giants GSK, Novo Nordisk Beat Expectations; But Novartis Dives On A Mixed Report
09:16am, Wednesday, 01'st Feb 2023
GSK stock and NVO stock rose Wednesday on fourth-quarter beats, but Novartis stock fell on lighter-than-expected sales despite strong profit. The post Pharma Giants GSK, Novo Nordisk Beat Expectations
GSK bidding to be first with an RSV vaccine. Here's our 2-minute guide
09:16am, Wednesday, 01'st Feb 2023
We heard earlier on Wednesday that GSK PLC (LSE:GSK, NYSE:GSK) could be the first to the market with a drug for RSV, a cold-like condition that can be deadly. Here we take a look at what exactly is an
